Ironically as Abbott reported earnings news comes from across the pond that Nemaura Medical is about to jump into the CGM pool. Per a story posted on the MassDevice web site;
“Nemaura Medical (NSDQ: NMRD) said today that it placed an initial order to its UK-based contract manufacturer for 12,500 rechargeable transmitters, designed as part of the company’s sugarBeat glucose monitoring systems.”
Never mind whether the sugarBeat works or not, never mind if they can successfully commercialize the damn thing no let’s start the betting pool right now. CGM is quickly becoming what BGM was 15 . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.